Browse > Article
http://dx.doi.org/10.5483/BMBRep.2010.43.7.461

Inhibitory effect of glyceollin isolated from soybean against melanogenesis in B16 melanoma cells  

Lee, Young-Sang (School of Life Science and Biotechnology, College of Natural Sciences, Kyungpook National University)
Kim, Hyun-Kyoung (N&B Co., Ltd., Kyungpook National University)
Lee, Kyung-Ju (N&B Co., Ltd., Kyungpook National University)
Jeon, Hye-Won (N&B Co., Ltd., Kyungpook National University)
Cui, Song (N&B Co., Ltd., Kyungpook National University)
Lee, You-Mie (School of Life Science and Biotechnology, College of Natural Sciences, Kyungpook National University)
Moon, Byung-Jo (School of Life Science and Biotechnology, College of Natural Sciences, Kyungpook National University)
Kim, Yong-Hoon (N&B Co., Ltd., Kyungpook National University)
Lee, Young-Sup (School of Life Science and Biotechnology, College of Natural Sciences, Kyungpook National University)
Publication Information
BMB Reports / v.43, no.7, 2010 , pp. 461-467 More about this Journal
Abstract
Natural products with non-toxic and environmentally friendly properties are good resources for skin-whitening cosmetic agents when compared to artificial synthetic chemicals. Here, we investigated the effect of glyceollin produced to induce disease resistance responses of soybean to specific races of an incompatible pathogen, phytophthora sojae, on melanogenesis and discussed their mechanisms in melanin biosynthesis. We found that glyceollin inhibits melanin synthesis and tyrosinase activity in B16 melanoma cells without cytotoxicity. To elucidate the mechanism of the effect of glyceollin on melanogenesis, we conducted western blot analysis for melanogenic enzymes such as tyrosinase, tyrosinase-related protein-1 (TRP-1), and TRP-2. Glyceollin inhibited tyrosinase and TRP-1 protein expression. Additionally, glyceollin effectively inhibited intracellular cAMP levels in B16 melanoma cells stimulated by $\alpha$-melanocyte stimulating hormone ($\alpha$-MSH). These results suggest that the whitening activity of glyceollin may be due to the inhibition of cAMP involved in the signal pathway of $\alpha$-MSH in B16 melanoma cells.
Keywords
cAMP; Glyceollin; Melanocyte; Tyrosinase; Tyrosinase-related protein;
Citations & Related Records

Times Cited By Web Of Science : 6  (Related Records In Web of Science)
Times Cited By SCOPUS : 10
연도 인용수 순위
1 Busca, R. and Ballotti, R. (2000) Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 13, 60-69.   DOI   ScienceOn
2 Seiberg, M., Paine, C., Sharlow, E., Andrade-Gordon, P., Costanzo, M., Eisinger, M. and Shapiro, S. S. (2000) Inhibition of melanisome transfer results in skin lightening. J. invest. Dermatol. 115, 162-167.   DOI   ScienceOn
3 Hearing, V. J. (2005) Biogenesis of pigment granules: a sensitive way to regulate melanocyte function. J. Dermatology Sci. 37, 3-14.   DOI   ScienceOn
4 Fitzpatrick, T. B. and Breathnach, A. S. (1963) The epidermal unit system. Dermatol. Wochenschr. 147, 481-489.
5 Martinez-Esparza, M., Jimenez-Cervantes, C., Beermann, F., Aparicio, P., Lozano, J. A. and Garcia-Borron, J. C. (1997) Transforming growth factor-beta1 inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1. J. Biol. Chem. 272, 3967-3972.   DOI   ScienceOn
6 Salvo, V. A., Boue, S. M, Fonseca, J. P., Elliott, S., Corbitt, C., Collins-Burow, B. M., Curiel, T. J., Srivastav, S. K., Shih, B. Y., Carter-Wientjes, C., Wood, C. E., Erhardt, P. W., Beckman, B. S., McLachlan, J. A., Cleveland, T. E. and Burow, M. E. (2006) Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis.Clin. Cancer Res. 12, 7159-7164.   DOI   ScienceOn
7 Boue, S. M., Carter, C. H., Ehrlich, K. C. and Cleveland, T. E. (2000) Induction of the soybean phytoalexins coumestrol and glyceollin by Aspergillus. J. Agric. Food Chem. 48, 2167-2172.   DOI   ScienceOn
8 Abdel-Malek, Z., Swope, V., Suzuki, I., Akcali, C., Harriger, M., Boyce, S., Urabe, K. and Hearing V. (1995) Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc. Natl. Acad. Sci. U.S.A. 92, 1789-1793.   DOI
9 Wakamatsu, K., Graham, A., Cook, D. and Thody, A. J. (1997) Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res. 10, 288-297.   DOI   ScienceOn
10 Cone, R. D., Lu, D., Koppula, S., Vage, D. I., Klungland, H., Boston, B., Chen, W., Orth, D. N., Pouton, C. and Kesterson, R. A. (1996) The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent. Prog. Horm. Res. 51, 287-317.
11 Tamagawa, T., Niki, H. and Niki, A. (1985) Insulin release independent of a rise in cytosolic free Ca2+ by forskolin and phorbol ester. FEBS Lett. 183, 430-432.   DOI   ScienceOn
12 Graham, T. L., Kim, J. E. and Graham, M. Y. (1990) Role of constitutive isoflavone conjugates in the accumulation of glyceollin in soybean infected with Phytophthora megasperma. Mol. Plant. Microbe. Interact. 3, 157-166.   DOI
13 Tachibana, M. (2000) MITF: a stream flowing for pigment cells. Pigment Cell Res. 13, 230-240.   DOI   ScienceOn
14 Zawa, V. P. and Mhaskar, S. T. (2004) Exogenous ochronosis following hydroquinine for melasma. J. Cosmet. Dermatol. 3, 234-236.   DOI   ScienceOn
15 Roh, J. S., Han, J. Y., Kim, J. H. and Hwang, J. K. (2004) Inhibitory effects of active compounds isolated from safflower (Carthamus tinctorius L.) seeds for melanogenesis. Boil. Pharm. Bull. 27, 1976-1978.   DOI   ScienceOn
16 Graham, T. L. and Graham, M. Y. (1991) Glyceollin elicitors induce major but distinctly different shifts in isoflavonoid metabolism in proximal and distal soybean cell populations. Mol. Plant. Microbe. Interact. 4, 60-68.   DOI
17 Daniel, O., Meier, M. S., Schlatter, J. and Frishknect, P. (1999) Selected phenolic compounds in cultivated plants: ecologic functions, health implications, and modulation by pesticides. Environ. Health Perspect 107, 109-114.   DOI
18 Bhattacharyya, M. K. and Ward, E. W. B. (1986) Resistance, susceptibility and accumulation of glyceollins I-III in soybean organs inoculated with Phytophthora megasperma f. sp. Glycinea. Physiol. and Mol. Pl. Pathol. 29, 227-237.   DOI
19 del Marmol, V. and Beermann, F. (1996) Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett. 381, 165-168.   DOI   ScienceOn
20 Payton-Stewart, F., Schoene, N. W., Kim, Y. S., Burow, M. E., Cleveland, T. E., Boue, S. M. and Wang, T. T. (2009) Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP. Mol. Carcinog. 48, 862-871.   DOI   ScienceOn
21 Hearing, V. J. and Tsukamoto, K. (1991) Enzymatic control of pigmentation in mammals. FASEB J. 5, 2902-2909.
22 Jackson, I. J., Chambers, D. M., Tsukamoto, K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A. and Hearing, V. J. (1992) A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J. 11, 527-535.
23 Kameyama, K., Takemura, T., Hamada, Y., Sakai, C., Kondoh, S., Nishiyama, S., Urabe, K. and Hearing, V. J. (1993) Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein 1 (TRP1), DOPAchrome tautomerase (TRP2), and a melanogenic inhibitor. J. Invest. Dermatol. 100, 126-131.   DOI   ScienceOn
24 Tsukamoto, K., Jackson, I. J., Urabe, K., Montague, P. M. and Hearing, V. J. (1992) A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J. 11, 519-526.
25 Aroca, P., Solano, F., Salinas, C., Garcia-Borron, J. C. and Lozano, J. A. (1992) Regulation of the final phase of mammalian melanogenesis. The role of dopachrome tautomerase and the ratio between 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole. Eur. J. Biochem. 208, 155-163.   DOI
26 Korner, A. and Pawelek, J. (1982) Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 217, 1163-1165.   DOI
27 Levy, C., Khaled, M. and Fisher, D. E., (2006) MITF: master regulator of melanocyte development and melanoma oncogene. Trends. Mol. Med. 12, 406-414.   DOI   ScienceOn